相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults
Priyanga Ranasinghe et al.
ANNALS OF EPIDEMIOLOGY (2021)
Carbonyl stress in diabetics with acute coronary syndrome
Sushmita Bora et al.
CLINICA CHIMICA ACTA (2021)
The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes
Jorge D. Erusalimsky
REDOX BIOLOGY (2021)
Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
Francesco Scavello et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Pathophysiology of diabetes mellitus and its complications: Metabolic events and control
Franklyn O. Ohiagu et al.
BIOMEDICAL RESEARCH AND THERAPY (2021)
AGE-RAGE Stress and Coronary Artery Disease
Kailash Prasad
INTERNATIONAL JOURNAL OF ANGIOLOGY (2021)
Microvascular Complications of Type 2 Diabetes Mellitus
Charles Faselis et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes
Magdalena Kopytek et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study
Se-Jun Park et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models
Lander Egana-Gorrono et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Kailash Prasad
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality
Helena Grauen Larsen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetes
Jacek T. Niedziela et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE
Foo Nian Wong et al.
PEERJ (2018)
The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
Sarah Louise Fishman et al.
MOLECULAR MEDICINE (2018)
Influence of ADAM10 Polymorphisms on Plasma Level of Soluble Receptor for Advanced Glycation End Products and The Association With Alzheimer's Disease Risk
Wen-Hui Huang et al.
FRONTIERS IN GENETICS (2018)
Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory
Sho-ichi Yamagishi et al.
JOURNAL OF DIABETES (2017)
Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2017
Joseph Fomusi Ndisang et al.
JOURNAL OF DIABETES RESEARCH (2017)
Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes
S. Goya Wannamethee et al.
ATHEROSCLEROSIS (2017)
Diabetes mellitus and its complications in India
Ranjit Unnikrishnan et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Demographic and angiographic profile in premature cases of acute coronary syndrome: analysis of 820 young patients from South India
Surender Deora et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2016)
Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes
Alan C. H. Lee et al.
PLOS ONE (2015)
Pancreatic stone protein/regenerating protein (PSP/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus
Jiayue Yang et al.
ENDOCRINE (2015)
Two Soluble Isoforms of Receptors for Advanced Glycation End Products (RAGE) in Carotid Atherosclerosis: The Difference of Soluble and Endogenous Secretory RAGE
Saori Moriya et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
Role of advanced glycation end products in cellular signaling
Christiane Ott et al.
REDOX BIOLOGY (2014)
Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
Keiko Fujisawa et al.
ATHEROSCLEROSIS (2013)
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes
Xystus H. L. Tam et al.
CLINICAL SCIENCE (2011)
Severity of diabetic microvascular complications is associated with a low soluble RAGE level
N. Grossin et al.
DIABETES & METABOLISM (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
分享论文
